Exact FDA event identifier

Event 78174

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: September 20, 2017
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: Deserving Health International Corp

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Symbio Muc Eye, 0.17 fl.oz. 5mL bottles, Manufactured for and distributed in the US b: Biological Health Group Corp. Bremerton, WA 98337. NDC 69711-125-61

D-0011-2018

Recall number: D-0011-2018
Initiated: September 20, 2017
Classification: Class II
Status: Terminated
Recalling firm: Deserving Health International Corp
Quantity: 623 dropper bottles

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot #: DM17B12, Exp 03/2020; DM16L44, Exp 12/2019; DM16L07, Exp12/2019

Distribution pattern

Product was distributed throughout the United States.